Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Bone Therapeutics S.A. | BOTHE | Apr 26, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Apr 26, 2024 | 3.73 | +3.47 |
Brederode S.A. | BREB | Apr 26, 2024 | 112.20 | +1.63 |
Campine nv | CAMB | Apr 26, 2024 | 75.00 | -2.60 |
Candela Invest | CAND | Apr 26, 2024 | 2.90 | 0.00 |
Care Property Invest NV/SA | CPINV | Apr 26, 2024 | 13.22 | +0.76 |
Celyad Oncology SA | CYAD | Apr 26, 2024 | 0.34 | +6.35 |
Cenergy Holdings | CENER | Apr 26, 2024 | 7.52 | -0.53 |
Chevron | CHTEX | Apr 26, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | Apr 26, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | Apr 26, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | Apr 26, 2024 | 62.00 | +0.81 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | Apr 26, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Apr 26, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Apr 26, 2024 | 43.38 | +1.02 |
Compagnie du Bois Sauvage S.A. | COMB | Apr 26, 2024 | 256.00 | +1.99 |
Compagnie d`Entreprises CFE SA | CFEB | Apr 26, 2024 | 7.67 | -0.78 |
Connect Group | CONN | Apr 26, 2024 | 1.53 | 0.00 |
Crescent NV | OPTI | Apr 26, 2024 | 0.01 | +1.56 |
Cumulex NV | CLEX | Apr 26, 2024 | 1.15 | 0.00 |
CURETIS | CURE | Apr 26, 2024 | 0.29 | 0.00 |
Deceuninck NV. | DECB | Apr 26, 2024 | 2.54 | +0.20 |
Deme Group N.V. | DEME | Apr 26, 2024 | 149.60 | +2.19 |
Deutsche Telekom AG | DTEL | Apr 26, 2024 | 20.00 | 0.00 |
Dexia SA | DEXB | Apr 26, 2024 | 0.30 | 0.00 |
Diegem KennedyCert | DIEG | Apr 26, 2024 | 124.00 | 0.00 |
Distri Land Le Certificat Foncier | DISL | Apr 26, 2024 | 210.00 | 0.00 |
DMS Imaging SA | DMSIM | Apr 26, 2024 | 0.02 | 0.00 |
DMS Imaging SA | ALIMG | Apr 26, 2024 | 0.02 | -9.09 |
D`ieteren Group | DIE | Apr 26, 2024 | 203.40 | +0.30 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.